- Report
- February 2024
- 175 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- February 2024
- 110 Pages
Global
From €4574EUR$4,750USD£3,934GBP
- Report
- January 2021
- 135 Pages
China, Global
From €3000EUR$3,337USD£2,670GBP
Teneligliptin is a drug used to treat endocrine and metabolic disorders. It is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which works by increasing the levels of incretin hormones in the body. This helps to reduce blood sugar levels in people with type 2 diabetes. Teneligliptin is also used to treat non-alcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS). It is available in tablet form and is usually taken once daily.
Teneligliptin is generally well tolerated, with the most common side effects being nausea, headache, and diarrhea. It is important to note that Teneligliptin should not be used in combination with other DPP-4 inhibitors, as this may increase the risk of hypoglycemia.
Teneligliptin is marketed by several companies, including AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, and Takeda Pharmaceuticals. Show Less Read more